Archives

  • 2026-10
  • 2026-09
  • 2026-08
  • 2026-07
  • 2026-06
  • 2026-05
  • 2026-04
  • 2026-03
  • 2026-02
  • 2026-01
  • 2025-12
  • 2025-11
  • 2025-10
  • Enantiomeric Polymer Structure Tunes IR-1061 Encapsulation f

    2026-06-07

    Enantiomeric Polymer Structure Tunes IR-1061 Encapsulation for NIR-II Imaging

    Study Background and Research Question

    Fluorescence bioimaging in the near infrared (NIR) region, particularly the second biological window (NIR-II, 1000–1350 nm), offers profound advantages for deep tissue visualization due to reduced absorption and scattering in biological tissues. While a range of nanomaterial-based fluorescent probes are available, organic dyes such as IR-1061 have attracted considerable attention for their low toxicity and minimal bioaccumulation potential. However, the hydrophobic and cationic molecular structure of IR-1061 complicates its deployment in aqueous biological environments, necessitating encapsulation strategies that preserve its fluorescence and prevent aggregation-induced quenching. A key unresolved question is how the chiral (enantiomeric) structure of hydrophobic encapsulation polymers—specifically poly(lactic acid) (PLA) variants—affects the encapsulation efficiency, molecular state, and photophysical performance of IR-1061 for in vivo deep imaging (Ichihashi et al., 2022).

    Key Innovation from the Reference Study

    The reference study introduces a systematic analysis of how the enantiomeric configuration of hydrophobic PLA polymers—poly(L-lactic acid) (PLLA) versus poly(DL-lactic acid) (PDLLA)—modulates the encapsulation behavior and fluorescence characteristics of IR-1061. By comparing these polymers, the authors provide new mechanistic insights into polymer–dye affinity, dye aggregation state (monomer versus dimer), and the resulting implications for designing highly emissive NIR-II fluorescent probes for deep tissue imaging.

    Methods and Experimental Design Insights

    To dissect the relationship between polymer structure and dye performance, the study prepared thin films of PLA with different chiralities, specifically PLLA (enantiomerically pure) and PDLLA (racemic mixture), and systematically encapsulated IR-1061 within these matrices. The encapsulation process exploited the hydrophobic interaction between the dye and the polymer core, mimicking the microenvironment of polymeric micelles commonly used for in vivo imaging probes. Detailed spectroscopic analyses—including absorption, emission, and fluorescence quantum yield measurements—were conducted to assess the aggregation state of IR-1061 (monomer versus dimer) and the stability of its fluorescence under different polymer environments. The study also evaluated the influence of counter ions and polymer hydroxyl groups on dye quenching, drawing on previous findings regarding BF4− stabilization versus OH−-induced quenching.

    Core Findings and Why They Matter

    The central findings reveal that IR-1061 exhibits a higher affinity for PDLLA than for PLLA, as evidenced by reduced dimerization within the racemic PDLLA environment (Ichihashi et al., 2022). Since dimerization of IR-1061 is associated with diminished fluorescence intensity, the ability of PDLLA to stabilize the monomeric (highly fluorescent) form of the dye is a critical parameter for maximizing imaging signal. These results are consistent with earlier work demonstrating that the dye’s molecular state and emission characteristics are highly sensitive to the polarity and chirality of the encapsulating polymer matrix (see Lima Prost Research).

    However, the study also highlights a trade-off: the stability of IR-1061 in PDLLA is lower than in PLLA, likely due to the influence of hydroxyl groups present in the racemic polymer, which may facilitate quenching pathways. This finding underscores the necessity of balancing polymer–dye affinity (to suppress aggregation) with microenvironmental stability (to prevent photobleaching or quenching) when designing NIR-II fluorescent probes for in vivo use.

    Importantly, these mechanistic insights provide a rational framework for selecting or engineering encapsulation polymers to tune the photophysical performance of IR-1061 and similar near infrared fluorescent dyes. This is especially relevant for researchers developing fluorescent dye-based platforms for optical and molecular imaging in challenging deep-tissue environments (Hyperfluor).

    Comparison with Existing Internal Articles

    Several recent internal reviews have emphasized the unique value of IR-1061 as a fluorescent dye for biomedical research, particularly in NIR-II deep tissue imaging applications. For instance, Lima Prost Research details protocol optimizations and troubleshooting for IR-1061, corroborating the reference study’s assertion that encapsulation conditions dramatically impact imaging performance. Hyperfluor further discusses how optimizing the polymeric encapsulation of IR-1061 is essential for achieving extended vascular visualization and precise molecular imaging. Both sources align with the reference paper’s findings that the molecular environment and microencapsulation strategy—not just the dye's intrinsic properties—are decisive for in vivo imaging quality.

    Moreover, mechanistic overviews such as Pepstatin-A highlight how the aggregation state of IR-1061 modulates its emission wavelength and intensity, reinforcing the importance of suppressing dimer formation—a central theme in the study by Ichihashi et al.

    Limitations and Transferability

    While the study offers critical mechanistic insights, certain limitations should be considered. The experimental work was performed in polymer film models rather than fully formulated in vivo nanocarriers, and the translation of these findings to complex biological systems may require further optimization, particularly regarding stability and biodistribution. The observed lower stability of IR-1061 in PDLLA suggests that while reduced dimerization is desirable, formulation strategies must also address potential quenching pathways associated with polymer end groups or environmental water ingress. Additionally, the study focused on PLA-based carriers, and the transferability of these principles to other biodegradable or amphiphilic polymers remains to be systematically explored.

    Protocol Parameters

    • Encapsulation Matrix Selection: Use PDLLA for higher IR-1061 monomer stabilization and fluorescence intensity; consider PLLA if greater dye stability is required over time (Ichihashi et al., 2022).
    • Dye Loading Concentration: Maintain IR-1061 at concentrations that favor monomeric dispersion in the selected polymer to minimize dimerization and fluorescence quenching.
    • Counter Ion Considerations: Ensure that BF4− is retained as the counter ion to suppress O–H vibration-induced quenching and maintain emission performance.
    • Solubility and Handling: Prepare IR-1061 in DMSO at ≥25.65 mg/mL; avoid ethanol and water due to insolubility, as recommended in product specifications.
    • Imaging Protocols: Optimize excitation and emission collection within the 1000–1350 nm window for maximal deep-tissue signal, referencing established NIR-II imaging protocols.

    Research Support Resources

    For researchers seeking to implement these findings in their own workflows, high-purity IR-1061 is available as IR-1061 (SKU C8242) from APExBIO, which provides detailed solubility and handling guidance to support reproducible encapsulation strategies. The product’s compatibility with DMSO and its validated photophysical properties align with the experimental parameters described above. Utilizing rigorously characterized IR-1061 allows researchers to focus on optimizing polymer selection and encapsulation protocols for advanced NIR-II imaging applications in biomedical research.